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The effectiveness of a domiciliary facial cooling therapy system on generic Quality of Life, 
following mandibular third molar removal 
 
INTRODUCTION 
Third molar extraction is the most commonly performed procedure by Oral and Maxillofa-
cial Surgeons in the UK (1). The surgical procedure to extract a M3M can be complicated by 
moderate to severe pain and swelling, and represent a significant amount of morbidity with-
in the immediate post-operative period for some patients (2). 
Quality of life (QoL) is defined as a patient’s perception of the impact of their disease and/ 
or treatment on their daily life, and their physical, psychological and social functioning or 
well-being (3). Previous studies focusing on QoL following M3M removal have shown a de-
terioration in “oral health-related quality of life”, to include pain and swelling, directly fol-
lowing their procedure (2,4,5,6,7).  
In this evaluation we used the EQ5D3L questionnaire (Figures 1 & 2). This instrument was 
originally derived to evaluate patient-reported impact of conditions and to compare the 
economic effectiveness of different interventions after conversion to a country-specific tar-
iff. In a previous validation study, we found that patients rank individual domains of the 
EQ5D3L as highly relevant measures of their QoL following M3M removal (8). We therefore 
chose to use individual domains of the EQ5D3L to evaluate the potential impact of hilother-
apy on QoL following M3M.  . 
The use of cooling compresses have traditionally been used for the reduction of postopera-
tive pain and swelling, however their effectiveness has been questioned in studies that ob-
jectively measure these parameters (9). The Hilotherm® non-domiciliary facial cooling sys-
tem delivers a consistent low therapeutic temperature (15°C), and meta-analyses have 
demonstrated a reduction in pain and swelling following orthognathic surgery, with excel-
lent patient compliance and improved patient satisfaction when compared to traditional 
cooling packs/ compresses (10).  
  
As part of a service evaluation we collected patient feedback on a novel Hilotherm® domicil-
iary facial cooling system in the early post-operative period following M3M removal. We 
aimed to evaluate ease of use, and effectiveness at improving QoL following M3M removal. 
METHODS 
We recorded patients’ Quality of Life (QoL) using the EQ5D3L Parts 1 & 2 (Figures 1 & 2), 
daily for 7 days, following M3M removal (permission granted for use by EuroQol Group 
Foundation on this patient number on 16/01/2014). Inclusion criteria were; Class I or II by 
the American Society of Anesthesiologists (ASA), aged 18 to 25 and non-smoker. They re-
quired removal of at least one horizontal, or mesio-angular impacted M3M with a surgical 
approach defined by the raising of a muco-periosteal flap, bone removal and tooth section-
ing. Exclusion criteria were; immunosuppressant diseases or drugs, chronic pain syndromes, 
and known illicit drug use. All patients were treated under a general anaesthetic by the 
same surgeon in the day surgery unit of a district general hospital.  
 
20 consecutive patients undergoing M3M removal without using the domiciliary facial cool-
ing system (Group 1) completed the EQ5D3L QoL survey. The questionnaire was printed on 
to seven sheets of A4 paper (one for each day), and patients were given a pre-paid envelope 
to return the completed questionnaire. 10 subsequent patients (Group 2) were given the 
domiciliary facial cooling system (Hilotherm®) to use for up to 7 days and were also asked to 
complete the same survey. An additional section was added to record patient satisfaction 
with the unit. After completion this survey was returned anonymously in a sealed envelope. 
Both groups received advice on post-operative analgesia. 
 
The Hilotherm® domiciliary facial cooling system consists of a mid/ lower face pre-
fabricated, polyurethane face-mask that is secured by 2 velcro® straps to go around the 
head. It is connected to a unit that can be filled with either cooled blocks or ice, and filled 
with tap water. This cooled water, regulated at around 15°C, circulates around the mask to 
channel the water to the lower face of the patient. Patients were given the manufacturer’s 
instruction leaflet, but were not showed how to apply or assemble the system before dis-
charge. They were advised to use it daily for as long or as little as they wished. 
 
  
For each questionnaire returned, the responses were collated in an anonymised database 
for each group. The response to questions 1-5 was coded following published guidance 
(euroqol.org) as follows; no complaint - score of 1, some problems - score of 2, a lot of prob-
lems - score of 3. For questions 1-5, The mean responses to questions 1-5 were calculated as 
the sum of all responses across the week, where higher scores indicate greater impact on 
QoL in that domain. The response to question 6, a visual analogue scale (VAS), was recorded 
as a numerical value lying closest to where the line drawn by the patient crossed the scale. 
The results for all respondents were collated and a mean score of responses to question 6 
with confidence intervals was calculated for each day. The lower scores indicate a greater 
impact on overall QoL. An ANOVA test was performed to assess for change in mean VAS 
score over time, with a post-hoc test between groups. Pairwise correlation of total scores 
for questions 1-6 was performed. All statistical analysis was undertaken using statistical 
package STATA (Statacorp 2015. Stats Statistical Software: Release 14 College Station, 
TX:StataCorp LP). 
 
On discussion with our local institutional research and development review board they 
granted an exception from the requirement for ethical approval for both groups in this pro-
spective service evaluation. This is because we routinely use a non-domiciliary facial cooling 
unit for patients following orthognathic surgery. We also routinely advise patients on the 
use of cold compresses following M3M removal. 
 
RESULTS 
Results 1: Group 1 - Generic QoL following M3M removal  
Of the 20 patients in Group 1 invited to take part, 14 returned surveys anonymously (re-
sponse rate of 70%). The completion rate of the EQ5D3L was 100% by respondents. 
 
Results 2: Group 2 - Generic QoL following M3M removal with domiciliary facial cooling   
All 10 patients invited to evaluate the Hilotherm® domiciliary facial cooling system accepted 
its use. Questionnaire response rate was 100%, and completion was 100%. This was made 
up of 3 males and 7 females. The mean age of respondents was 21 years and 6 months.  
 
Results 3: Collated responses of questions 1 – 5 of EQ5D3L Part 1 (Figure 1) Groups 1 & 2.  
  
In all 5 items, QoL was reduced and then improved during the early post-operative period. 
By day seven, no individuals reported severe reduction in QoL for any item. The greatest re-
duction in QoL on every day, was in the pain or discomfort item. Each day QoL was im-
proved for Group 2 compared to Group 1 demonstrated in a radar graph (Figure 4). 
 
Results 4: Part 2 EQ5D3L (Figure 2) was calculated for a 20cm vertical VAS. This is a score of 
global well-being which was recorded each day post-operatively, and scored out of 100. Re-
spondents’ results from Groups 1 & 2, were collated separately, and a mean score for each 
day calculated. The mean and the trend, is shown in the graph in Figure 3 for both 
groupsVAS scores improved at approximately 5.7 points per day during the first week after 
M3M removal.. Considered across all 7 days, the mean VAS scores were approximately 7.8 
points better in participants who received domiciliary cooling compared to participants who 
did not (p = 0.004).  
 
Results 5: Daily use (in hours) patients in Group 2 applied the Hilotherm® domiciliary facial 
cooling system. The daily mean for use is displayed in Table 1. None of Group 2 used the 
domiciliary unit on day 7, and used it very little on day 6. 
 
Results 6: Ease of use and comfort of domiciliary facial cooling system.  
Experience of the domiciliary facial cooling system was positive (Figure 5). All patients that 
used the unit gave either positive or very positive feedback. On the whole the group found 
it unit easy to use, comfortable and said that the temperature was ideal. The mean “useful-
ness” was 7.8 out of 10 (10 = maximum usefulness).  
 
DISCUSSION 
Complications following M3M surgery have been published (2,4,5,6,7), but less evidence is 
available describing patient’s generic QoL in the early post-operative period. Recently, the 
importance of patient reported outcome measures (PROMS), are being recognised during 
the commissioning of healthcare services in the UK (11,12,13), as is the importance of 
providing information regarding risks and side effects of procedures during the consenting 
process. For these reasons, interventions which mitigate the side effects of surgery are of 
interest to providers and patients. 
  
 
Traditionally cold compresses have been used to treat pain and swelling in the period direct-
ly following bodily injury or surgery (14). Studies in oral and maxillofacial surgery have com-
pared the application of traditional cold compresses vs the Hilotherm® non-domiciliary faci-
al cooling system on swelling following orthognathic surgery (15,16), bilateral mandibular 
fracture fixation (17), zygomatic fracture fixation (18), face lift surgery (19) and third molar 
extraction (20,21).  
 
Cold therapy has effects on nerve conduction, local vasculature, muscles and metabolic pro-
cess (22). Physiological cooling is known to exert an autonomic-mediated effect which in-
duces vasoconstriction which, in theory, should minimize oedema and ecchymosis of the 
tissues (23). Cold compresses often have a temperature which starts at around 0°C and rap-
idly warms to room temperature, compared to a Hilotherm facial cooling system that con-
stantly runs at around 15°C. This is the temperature at which vasoconstriction is at its most 
intense and hence should have the best anti-oedema effect. Peripheral nerve conduction, 
inflammation and pain, is also reduced (22).  
 
Below 15°C these effects are reduced, and at 0°C, nerve conduction is completely disabled 
and vasoconstriction reverts to vasodilation. Extreme low temperatures also constrain 
lymph drainage and cell metabolism, which increases oedema (22). Keeping constant cool-
ing temperature over the operation site at around 15°C should result in a reduction in pain 
and swelling, and consequently improve QoL in the early post-operative period. Two recent 
systematic reviews and meta-analyses (9,24) have described a significant improvement in 
pain and swelling after facial surgery with the use of a hilotherapy system. Jones et al meas-
ured pain on a VAS (19) similar to the EQ5D3L Part 2 (Figure 2), but none of these studies 
have examined the impact on QoL. 
 
In our service evaluation we demonstrate a significantly improved QoL for the 7 days of the 
evaluation, when comparing Group 1 (no cooling unit) and Group 2 (domiciliary facial cool-
ing unit). Of particular note is the improvement seen on the EQ5D3L Part 2 VAS scoring for 
Group 2 vs. Group 1 on days 3-5. These results are in keeping with current literature findings 
  
that facial cooling therapy improves patient perception of pain and swelling most notably on 
Day 2 post-surgery (9,19, 24). 
 
“Return to normal activities” was sooner in Group 2 of our evaluation suggesting that the 
domiciliary facial cooling system improves the post-operative experience for both physical 
symptoms i.e. “pain/ discomfort” and also general personal well-being i.e. “overall QoL”. 
“Anxiety/ worry” was also improved every day post-surgery in Group 2 vs Group 1. These 
findings support the idea that addressing “pain/ discomfort” improves the domains of “anx-
iety/ worry”, and “overall QoL” has been demonstrated in this group of patients.  
 
Experience of the ease of use and comfort of the domiciliary facial cooling system was posi-
tive. The duration of use of the system (Table 1) was also interesting. Our results demon-
strate the biggest difference in QoL between Groups 1 & 2 on days 3-5 and since the use of 
the unit diminishes at that point, this would tend to support the suggestion that the unit 
was only necessary in the 5 days post-operatively. This means there are 2 days in which this 
could be used by another patient. This type of information has value when compiling a busi-
ness case to gain funding for a new form of treatment or intervention. 
 
Our evaluation has several limitations and the therapeutic effects should be interpreted 
with caution. 6 patients (30%) patients in Group 1 did not complete the EQ5D3L and return 
it to us. If these patients had a better post-operative experience than the people who re-
turned their surveys this could have resulted in a reporting bias which over-estimates how 
bad the early post-operative experience was, and give the appearance that the facial cooling 
unit improved QoL more than it did. 
 
Our sample size is small, as there were no prior power calculations, therefore we 
acknowledge the lack of precision our results may give. As our study was a feasibility or pilot 
study we felt a prior power calculation was not necessarily appropriate (25) and we also had 
no prior indication as to the likely difference in PROMs between both groups. The difference 
in PROMs between the two groups could be used as a basis to power a future randomised 
control trial leading on from this study with larger numbers of participants. 
 
  
Another limitation is that the evaluation was not blinded. Group 2 knew they were using the 
facial cooling unit and there may have been a placebo effect to give more favourable an-
swers because they felt they were receiving a new treatment. After M3M removal they 
were reassured that their questionnaires were to be placed in a sealed and unmarked enve-
lope giving anonymity, and the forms were completed in the privacy of participants own 
homes which mitigated against bias. 
 
There was no objective measurement of pain and swelling in the patients included in this 
project, but since this study focusses on QoL we do not consider this a significant weakness. 
QoL was also not recorded on an EQ5D3L questionnaire directly pre-operatively in either 
group, and is recognised as a minor limitation of this study.  As the therapeutic effects of 
hilotherapy have already been proven (9,24) this evaluation was not designed to prove effi-
cacy, but simply to evaluate the ease of use, and the effect of using hilotherapy in a domicil-




EQ5D3L has been shown to be a responsive tool in the assessment of QoL following M3M 
removal. It evaluates generic QoL providing data on return to normal activities, and patient 
perception of improvement in pain and swelling, which is information our patients have re-
ported is most important to them.  
 
With the growing importance of patient reported outcome measures (PROMs) following 
medical intervention, it is necessary to look at ways to improve these outcomes. This evalu-
ation suggests that a domiciliary facial cooling system is easy to use, and improves QoL in 
the early postoperative period following M3M removal. 
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Figure/ table legend 
Table 1: Length of time in hours that patients in Group 2 applied the Hilotherm® domiciliary 
unit each day. 
Figure 1: EQ5D5L Survey Part 1  
Figure 2: EQ5D5L Part 2 visual analogue scale (VAS) 
Figure 3: Change in mean VAS over time EQ5D5L Part 2 Groups 1 & 2 
Figure 4: Collated and compared responses of questions 1 – 5 of EQ5D5L Part 1 (Figure 1) 
Groups 1 & 2 
  
Figure 5: Patient satisfaction of hilotherapy unit 
